000			02061 a2200589 4500
005			20250513115041.0
264		0	_c19970424
008			199704s 0 0 eng d
022			_a0041-1345
024	7		_a10.1016/s0041-1345(96)00444-7 _2doi
040			_aNLM _beng _cNLM
100	1		_aMattsson, J
245	0	0	_aA low incidence of grade II to IV acute GVHD, but high mortality from infection using HLA-A, -B, and -DR-identical unrelated donors and immunosuppression with ATG, cyclosporine, and methotrexate. _h[electronic resource]
260			_bTransplantation proceedings _c
300			_a735-6 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article
650	0	4	_aAcute Disease
650	0	4	_aAdult
650	0	4	_aAntilymphocyte Serum _xtherapeutic use
650	0	4	_aBone Marrow Transplantation _ximmunology
650	0	4	_aCommunicable Diseases _xmortality
650	0	4	_aCyclosporine _xtherapeutic use
650	0	4	_aGraft vs Host Disease _xepidemiology
650	0	4	_aHLA-A Antigens
650	0	4	_aHLA-B Antigens
650	0	4	_aHLA-DR Antigens
650	0	4	_aHistocompatibility Testing
650	0	4	_aHumans
650	0	4	_aImmunosuppression Therapy _xmethods
650	0	4	_aImmunosuppressive Agents _xtherapeutic use
650	0	4	_aIncidence
650	0	4	_aLeukemia _xtherapy
650	0	4	_aLiving Donors
650	0	4	_aLymphoma _xtherapy
650	0	4	_aMetabolism, Inborn Errors _xtherapy
650	0	4	_aMethotrexate _xtherapeutic use
650	0	4	_aMultiple Myeloma _xtherapy
650	0	4	_aMyelodysplastic Syndromes _xtherapy
650	0	4	_aNuclear Family
700	1		_aRingdén, O
700	1		_aAschan, J
700	1		_aBarkholt, L
700	1		_aDalianis, T
700	1		_aHägglund, H
700	1		_aLjungman, P
700	1		_aLönnqvist, B
700	1		_aTollemar, J
700	1		_aWiniarski, J
700	1		_aRemberger, M
773	0		_tTransplantation proceedings _gvol. 29 _gno. 1-2 _gp. 735-6
856	4	0	_uhttps://doi.org/10.1016/s0041-1345(96)00444-7 _zAvailable from publisher's website
999			_c9105028 _d9105028